Skip to content

Getting antiretrovirals to where they are needed

Extra £24 million of UK government funding for microbicide gel trial

Benefits of genotypic testing confirmed in French clinic study

Genetic differences predict triglyceride increase on ritonavir-boosted PI

UK sexual health services improving, but many clinics still struggling to cope

HIV diagnosed later in Africans in south London

Lack of HIV knowledge equals poorer doctor attitude to HIV-positive IV drug users

Study in southern Mexico reports that DOTS programme can reduce the prevalence of drug resistant TB

HIV causes metabolic disturbances in the absence of antiretroviral therapy